82 related articles for article (PubMed ID: 6108651)
1. Disposition in rats and mice of chloropractolol, a new beta-blocking agent.
Godeneche D; Pilichowski JF; Meyniel G
Xenobiotica; 1980 Sep; 10(9):725-33. PubMed ID: 6108651
[TBL] [Abstract][Full Text] [Related]
2. Practolol metabolism in various small animal species.
Reeves PR; McCormick DJ; Jepson HT
Xenobiotica; 1979 Jul; 9(7):453-8. PubMed ID: 115161
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys.
Sasaki H; Kamimura H; Kaniwa H; Kawamura S; Takaichi M; Yokoshima T
Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
6. The metabolic disposition of the selective beta 1-adrenoceptor agonist prenalterol in mice, rats, dogs, and humans.
Hoffmann KJ; Arfwidsson A; Borg KO
Drug Metab Dispos; 1982; 10(2):173-9. PubMed ID: 6124405
[TBL] [Abstract][Full Text] [Related]
7. The uptake and overflow of radiolabelled beta-adrenoceptor blocking agents by the isolated vas deferens of the rat.
Lewis MJ
Br J Pharmacol; 1977 Aug; 60(4):595-600. PubMed ID: 20192
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
10. Can chloropractolol alkylate beta adrenoceptors?
Kenakin TP; Black JW
Nature; 1977 Jan; 265(5592):365-6. PubMed ID: 13308
[No Abstract] [Full Text] [Related]
11. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
12. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
13. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
14. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological classification of practolol and chloropractolol.
Kenakin TP; Black JW
Mol Pharmacol; 1978 Jul; 14(4):607-23. PubMed ID: 28471
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
[TBL] [Abstract][Full Text] [Related]
18. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of atenolol in animals.
Reeves PR; Barnfield DJ; Longshaw S; McIntosh DA; Winrow MJ
Xenobiotica; 1978 May; 8(5):305-11. PubMed ID: 96616
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, elimination and metabolism of 14C-heptaminol hydrochloride in rat.
Chanoine F; Benedetti MS; Ancher JF; Dostert P
Arzneimittelforschung; 1981; 31(9):1430-5. PubMed ID: 7197949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
